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Ferrets or mice recovered from infection with the virus of human 
or  swine influenza are  usually immune to  infection with the other 
virus (1-3).  In these two animals a  complete and frequently fatal 
disease is produced by either type of influenza virus alone, and there 
is no evidence that concomitant infection with Hemophitus influenzae 
suis or any other bacterium modifies its course in any constant manner 
(1,  3-6).  Swine, on the other hand, infected with either swine or 
human influenza virus alone develop but a mild, transient, indefinite 
illness (filtrate disease) and come down with influenza only when the 
bacterium, H. influemae suis  (7), has accompanied the virus (8-10). 
It seemed possible that the cross-immunological relationship between 
swine and human influenza virus found in the simple virus infections 
of ferrets and mice might not follow in the complex virus-bacterium 
infections necessary to induce influenza in swine.  The present paper 
reports experiments dealing with the cross-immunization of swine by 
means of initial infections with either swine or human influenza virus 
alone or in mixture with the bacterium, H. influenzae suis. 
EXPERIMENTAL 
Infectious Materials Used 
Francis' P.R. 8 strain  (5)  human influenza virus and strain  15  (Iowa, 1930) 
swine influenza virus were employed in all experiments.  Culture 18 (11) H. influ- 
enzae suis  was used  to  complete  the  etiological complex with  either  strain  of 
virus in most cases, although in a few instances this was pooled with cultures 23 
and 24, more recently isolated from field  cases of swine influenza. 
Virus, either the human or the porcine type, was in all experiments prepared 
in physiological saline as a 10 per cent suspension of lung from swine infected with 
virus alone.  The swine strain had originally been freed of H. influenzae suis by 
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Berkefeld  filtration  or by serial passage  through ferrets  or mice.  Swine  whose 
infections  were to be with virus alone were given from 6 to 10 cc. of the super- 
natant fluid from sedimented  but uncentrifuged  suspensions intranasally.  Swine 
whose infections  were to be with a mixture of virus and bacterium received,  in 
addition to virus, 0.5 to Icc. of a 24 hour horse blood culture 1  of H. influenzae suis. 
The culture was mixed with the virus suspension just prior to its administration 
intranasally.  Variations  in the dosage of either virus or bacterium, within the 
limits used in the present experiments, had no influence on the results obtained. 
Immunity to Swine Influenza Induced by Infection with Human 
Influenza Virus Alone or in Mixture with Hemophilus 
influenzae suis 
Eight swine were inoculated  intranasally with a mixture of human influenza 
virus and H. influenzae suis.  As noted in Table I, 6 of these animals developed 
an  illness that  was  clinically  characteristic  of  a  mild  swine  influenza.  The 
remaining  2 came down with an illness which clinically resembled that produced 
in swine by infection  with virus alone, and it is believed that in these tt. influ- 
enzae suis failed  to become established  with the virus in the respiratory tract. 
The occasional failure of this bacterium to establish  itself with human influenza 
virus in the swine respiratory tract is well known from earlier work (10). 
Nine swine inoculated intranasally with human influenza virus alone developed 
the mild,  indefinite,  filtrate  disease.  2 other swine receiving  human influenza 
virus alone intranasally twice at 20 day intervals  exhibited  symptoms of filtrate 
disease following the first  inoculation  only. 
When the swine had completely  recovered from their human influenza infec- 
tions  they were  tested  for immunity to  swine  influenza  by inoculating  them 
intranasally,  together with control swine, with a mixture of swine influenza virus 
and H. influenzae suis.  The results  of these  tests  for immunity are outlined 
in Table I. 
As shown in the table,  6 of the 8  swine whose initial infection had 
been with a  mixture of human influenza virus and H. influenzae suis 
proved immune to swine influenza.  Of the remaining animals,  swine 
1820 developed a transient fever but did not appear ill, while the other 
one,  swine  1823,  whose  initial  infection  had  clinically  resembled 
filtrate  disease,  was  febrile  and  depressed  and  exhibited  a  scattered 
lobular pneumonia when autopsied on the 3rd day.  Swine influenza 
virus  was  demonstrated,  by mouse  inoculation,  in  the  lung  of  this 
animal although its presence could not be demonstrated in the turbi- 
10.5  to 1 cc. of sterile  defibrinated  horse blood added to a  plain agar slant. 
In this medium H. influenzae suis grows largely in the blood at the base of the 
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hates.  H. influenzae suis could not be cultivated from either the lung 
or terminal bronchi. 
Four of the 6 swine that had appeared clinically immune to swine 
influenza were killed and autopsied on the 3rd or 4th day after inocula- 
tion.  No  lesions  of swine  influenza were seen in  their respiratory 
tracts.  Their lungs appeared normal aside from scant, old, puckering 
scars in the anterior lobes,  evidently residual for their initial human 
influenza  infection. Virus  could  not  be  demonstrated  by  mouse 
inoculation in the lungs of any of the animals nor in the turbinates of 2 
tested.  Neither could H.  influenzae  suis  be  cultivated from their 
lungs or terminal bronchi.  Autopsy thus confirmed the clinical evi- 
dence that these 4 swine had been immune to swine influenza.  The 
remaining 3 of the 8  swine  initially infected with human influenza 
virus and H. influenzae suis were kept under observation in order later 
to obtain serum for neutralizing antibody studies. 
The results obtained in the swine whose initial infections had been 
with human influenza virus alone differed from those just described. 
Only 1 animal, swine  1780, proved completely immune to swine in- 
fluenza.  The remaining 8 developed disease varying clinically from 
that seen in normal swine  infected with swine  influenza to  that in 
which the salient features were merely a transient depression with or 
without fever.  6 of these animals were killed and autopsied on the 
3rd or 4th day.  One, swine  1729, showed no influenzal pneumonia; 
1,  swine  1747, showed only a  pleuritis; while,  in  the  remaining 4, 
pneumonias of from 1 to 3 lobes were encountered.  These pneumo- 
nias were qualitatively like those seen in the control animals but were 
in  most  cases  less  extensive.  However,  although  swine  influenza 
virus was regularly detectable by mouse inoculation in the turbinatea 
and lungs of the control swine, it was either not demonstrated or pres- 
ent only in low concentrations  in the turbinates and lungs of the human 
virus-lmmune animals.  H. influenzae  suis could be cultivated from 
the lungs of 4 of the 6 swine autopsied and from the terminal bronchi 
of all.  Its presence in this group of animals was in striking contrast 
to its uniform absence in the lungs and terminal bronchi of the swine 
whose initial infection had been with a mixture of human virus and 
H. influenzae  suis. 
The 2 swine that had been inoculated intranasally twice at 20 day 
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immune to swine influenza when later tested.  They, together with 3 
swine  receiving a  single  injection of human  influenza  virus  prior  to 
testing for immunity to swine influenza, were kept under observation 
in  order  subsequently  to  obtain  serum  for  neutralizing  antibody 
studies. 
It would appear from these experiments that, while initial infection 
with a mixture of human influenza virus and H. influenzae suis usually 
immunizes swine to swine influenza, initial infection with the human 
virus  alone usually fails to  do  so,  although it does appreciably alter 
their  susceptibility.  That  the  cross-immunity  to  swine  influenza 
conferred by a  primary infection with  the human  agent is not asso- 
ciated with  demonstrable virus-neutralizing antibodies  for the  swine 
virus  is indicated  by the  fact that  the  sera  of all  19  swine  studied, 
obtained  just  prior  to  the  inoculation  test  for  immunity  to  swine 
influenza,  failed  to  neutralize  the  swine  agent.  All,  however,  neu- 
tralized the human virus completely. 
Technique  of  the  Neutralization  Tests.--The  neutralization  tests  recorded 
throughout this paper were conducted in the usual way in mice (12), employing 
the snpernatant of a 2 per cent suspension  of infected mouse lung as virus and 
mixing this in equal parts with the undiluted sera to be tested.  Either 3 or 4 
mice, while under ether narcosis,  were inoculated in each test by dipping their 
noses in the virus-serum mixture contained in a slightly tilted Petri dish.  Sur- 
viving mice were killed on the 7th day and their lungs,  together with those of 
mice dying earlier, were examined for the presence of influenza  lesions.  Mice 
which  survived  7  days and  whose  lungs  showed  no  influenzal  pneumonia  at 
autopsy were considered to have received a completely neutralizing serum, mice 
which survived 7 days but whose lungs showed influenzal lesions at autopsy were 
considered  to have received a partially neutralizing serum, while mice which died 
of an influenzal pneumonia during the period of observation were considered  to 
have received a non-neutralizing serum.  The swine and human viruses employed 
in the neutralization tests were of such virulence as to kill all control mice within 
7 days. 
Immunity  to  Human  Influenza  Infection  2 Induced  by  Infection  with 
Swine Influenza or Swine Influenza Virus Alone 
Six swine inoculated intranasally with a mixture of swine influenza virus and 
H.  influenzae suis  developed swine  influenza.  8  swine  inoculated intranasally 
In order to simplify terminology, "human influenza infection" is used to indi- 
cate an infection with a mixture of human influenza virus and H. influenzae suis. gIc~r.D  E.  srmPE  157 
with swine influenza virus alone came down with filtrate  disease.  Following 
complete recovery all 14 animals were tested for immunity to human influenza 
infection by inoculating them intranasally,  together  with control swine, with 
a mixture of human influenza virus and H. influenzae suis.  The results of these 
tests for immunity are given in Table II. 
As shown in the table, all 6 of the swine initially infected with swine 
influenza proved clinically immune to human influenza infection.  2 of 
these animals were killed and autopsied on the 4th day after inocula- 
tion.  No lesions of human influenza infection were seen in their respir- 
atory tracts and their lungs appeared normal aside from old healing 
lesions in the anterior lobes, residual from the initial swine influenza 
infections.  Virus  could not be demonstrated by mouse inoculation 
in the lungs or turbinates and H. influenzae suis could not be culti- 
vated from either the lungs or terminal bronchi.  Clinical evidence of 
immunity was thus confirmed by postmortem findings.  The remain- 
ing 4  swine in the group were saved for later neutralizing antibody 
studies. 
Of the 8 swine initially infected with swine influenza virus alone, 6 
proved  clinically immune to  later human influenza infection.  The 
remaining 2 became ill,  but in neither of these were the postmortem 
findings characteristic of a  human influenza infection.  One animal 
(swine 1778)  showed no recent respiratory tract lesions at all, merely 
an old, unresolved, scattered, lobular pneumonia probably persisting 
since the initial swine virus infection.  The other animal (swine 1673) 
had a bilateral fibrinous pleuritis and pericarditis and from the exudate 
H.  influenzae  suis  and  a  streptococcus  were  cultivated.  2  of  the 
clinically immune animals killed and autopsied 4 days after inoculation 
showed no lesions of human influenza infection.  In the anterior lobes 
of the lungs of both animals were scant contracted old scars evidently 
the result of healing swine influenza virus lesions.  Virus could not be 
demonstrated by mouse inoculation in the turbinates or lungs of any 
of the 4  swine autopsied.  The remaining 4  swine in the group, all 
clinically  immune  to  human  influenza  infection,  were  kept  under 
observation for later neutralizing antibody studies. 
It is  apparent from these experiments that initial infection with 
both the agents responsible for swine influenza or the swine influenza 
virus alone usually immunizes swine to human influenza infection, and 158  SWINE  AND  HUMAN  INFLUENZA  VIRUSES  IN  SWINE 
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TABLE  III 
Influence  of Initial  Virus Infection  upon  Subsequent Antibody  Response to  the 
Viruses of Human and Swine Influenza 
Swine 
No.  Serum drawn 
Serum tested for capacity to neutralize 
Swine influenza virus  Human influenza virus 
Extent of pulmonary  leslons  Extent of pulmonary  leslons 
in mouse No.  in mouse No. 
'1 1 1, 115131, 











12 days after initial infection 
12 days after reinoculation 
Normal 
12 days after initial infection 
12 days after reinoculation 
Normal 
12 days after initial infection 
12 days after reinoculation 
Normal 
19 days after initial infection 
11 days after reinoculafion 
Norn'lal 
31 days after initial infection* 
11 days after reinoculation 
Normal 
31 days after initial infection* 
11 days after reinocuiafion 
Normal 
12 days after initial infection 
11 days after reinoculation 
Normal 
12 days after initial infection 

























4+  4+i 
4+  4+ 
0  0 
4+  4+ 
4+  4+ 
1+  1+ 
I 
4+  4+ 
4+  4+l 
0  0 
4+  4+ 
4+  4+ 
0  0 
4+  4+ 
4+  4+ 
0  0 
4+  4+ 
4+  4+ 
0  0 
4+  4+ 
4+  4+ 
0  0 
4+  4+ 
4+  4+ 
4+  4+ 
4+  4+ 
3-1-  0 
0  0 
4+  4+ 
3+  0 
0  0 
4+  4+ 
4+  0 
0  0 
4+  4+ 
0 
0  0 
4+  4+ 
4+  0 
0  0 
4+  4+ 
4+  0 
0  0 
4+  4+ 
4+  0 






















4+  4+  [4+ 
4+  0  [1+ 
4+  0  0 
4+  4+ 
0  0 
0  0 
4+  I4+ 
0  0 
0  0 
4+ 
0  0 
0  0 
4+  4+ 
0 
0  0 
4+  j4+ 
0  0 
0  0 
4+  4+ 
0  0 
0  0 
4+  14+ 
0  0 
0  0 
4+  [4+ 
0  0 
0  0 
* 0  =, mouse with no pulmonary lesions at autopsy.  1 +  to 4 +  =  mice with 
progressive degrees of influenzal pneumonia; 4+ indicates a  complete and fatal 




No.  Serum drawn 
Serum tested for capacity to neutralize 
Swine influenza vir~  Human influenza vir~ 
Extent of pulmonary lesions I Extent of pulmonary lesions 
in mouse No.  ]  in mouse No. 
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Normal (not obtained) 
22 days after initial infection 
12 days after reinoculation 
Normal 
13 days after initial infection 
12 days after reinoculation 
Normal 
13 days after initial infection 
12 days after reinoculation 
Normal (not obtained) 
16 days after initial infection 
12 days after reinoculation 
Normal 
14 days after initial infection 
12 days after reinoculation 
Normal 
14 days after initial infection 
12 days after reinoculation 
Normal 
12 days after initial infection 
11 days after reinoculation 
Normal 
12 days after initial infection 
11 days after reinoculation 
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0  2+ 
o  4+ 
0  4+ 
4+  4+ 
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o  1+ 
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4+ 
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4+  4+ 
0  0 
4+  4+ 
3+  3+ 
3+  2+ 
4+  4+ 
4+  2+ 
2+  2+ 
4+  4+ 
4+  4+ 
4+  4+ 
4+  4+ 
1+  1+ 
4+  4+ 
4+  3+ 
3+  2+ 
4+  4+ 
2+  1+ 
2+  2+ 
4+  4+ 
4+  3+ 
4+  3+ 
that  the vires alone is little if any less effective in achieving immunity 
than is a mixture of virus and H. infl~n~,ae suis.  The cross-immunity 
to  human  influenza  infection  conferred  by  the  porcine  agent  is  not 162  SWINE  AND  Jc[UMAN  INFLUENZA  VIRUSES  IN  SWINE 
usually  associated  with  demonstrable  virus-neutralizing  antibodies 
for the human virus.  Of the  14 swine studied,  the serum of only 1 
(swine 1744), obtained just prior to the test for immunity to human 
influenza infection, exerted any neutralizing effect on the human virus. 
The remaining 13 sera, although neutralizing swine virus completely, 
were devoid of neutralizing activity for the human agent. 
Influence of Initial  Virus Infection upon Subsequent Antibody Response 
to the Viruses of Human and Swine Influenza 
In  order  to  determine whether  swine  would  develop  neutralizing 
antibodies for either swine or human influenza virus, when inoculated 
intranasally  with  these  agents  following  recovery  from  an  initial 
infection  in  which  the  heterologous  virus  had  been  employed,  the 
fonowing experiments were carried out. 
Eight swine recovered from infection with either human influenza virus alone 
or a mixture of human influenza  virus and H. influenzae suis were reinoculated 
intranasally with a mixture of swine influenza virus and H. influennae suis.  Some 
proved clinically immune and others not, as recorded in Table I.  11 or 12 days 
after reinoculation they were bled and the serum then obtained, together with 
that secured before and following recovery from their initial infection, was tested 
for the presence of neutralizing antibodies for the swine and human viruses by 
the usual technique (12). 
Eight further swine recovered from infection with  swine  influenza  or  swine 
influenza  virus alone were reinoculated intranasany with  a  mixture of human 
influenza virus and H. influenzae suis.  All proved clinically immune, as recorded 
in Table II.  Like those in the preceding group, they were bled 11 or 12 days 
after reinoculation and  the serum obtained, together with that  drawn  before 
and following recovery from their initial infection, was  tested for neutralizing 
antibodies against both viruses.  The results of the tests of these 2 groups of 
swine  sera are outlined in  Table III.  Since  the development of neutralizing 
antibodies for either swine or human influenza virus was independent of whether 
or not H. influenzae suis had accompanied the virus in the infection, no dis- 
tinction is made in the table between the animals initially infected with virus 
alone and those infected with a mixture of virus and bacterium. 
As  shown in the table,  it was  found that  the  sera of all  8  swine, 
obtained  following  recovery  from  an  initial  infection  with  human 
influenza  virus,  neutralized  the  human  but  not  the  swine  agent. 
Reinoculation of these animals intranasally with swine influenza virus 
resulted in  the  appearance,  in  sera obtained  11  or  12  days later,  of I~ICHA~D E.  SHOI'E  163 
antibodies neutralizing the swine virus completely in 6 of the 8 cases. 
In the serum of 1 animal (swine 1820)  a weaker titer of swine virus 
antibody  appeared,  while  in  the  serum  of  the  remaining  animal 
(swine  1780)  no  swine  virus-neutralizing  antibodies  were  demon- 
strated.  Antibodies developed independently of whether or not the 
animals  exhibited  recognizable  clinical  manifestations  of  infection 
following reinoculation with swine influenza. 
The results obtained in studies with sera of swine initially infected 
with  swine influenza  virus  and  reinoculated intranasally  with  the 
human agent were quite different from those just described.  Only 1 
(swine  1678)  of the 8  swine developed antibodies which completely 
neutralized the human virus.  2 others (swine 1667 and 1787) devel- 
oped antibodies which neutralized partially under the conditions of the 
test.  The sera of the remaining 5 swine failed to show a  significant 
increase in neutralizing antibodies for the human virus.  Swine 1744, 
whose serum drawn before reinoculation with the human virus par- 
tially neutralized, still only partially neutralized afterwards. 
It seems clear from the experiments just described that the swine 
and human influenza viruses influence the subsequent immunological 
reactivity of swine in  differing fashions.  To  summarize,  swine re- 
covered from infection with swine influenza virus are not only immune 
to the human influenza virus but usually fail to develop specific virus- 
neutralizing antibodies for it following intranasal inoculation.  Swine 
recovered from initial infection with human influenza virus, on the 
other hand, may or may not prove immune to swine influenza, but 
whether  or  not  immune,  usually  elaborate  swine  influenza  virus- 
neutralizing antibodies. 
The  Antibody  Response of  Swine  Influenza-Convalescent Swine  to 
Human Influenza Virus Administered Intramuscularly 
There were two obvious possible explanations for the general failure 
of swine influenza-recovered swine to develop neutralizing antibodies 
for the human influenza virus following intranasal inoculation.  First, 
the immunity conferred by a previous infection with the swine virus 
might be of such a nature as to render the respiratory tract mucosa 
actually impermeable to the human virus.  If this were the case and 
human virus were  completely prevented from invading susceptible 164  SWI~rE  AND  HUMAN  INleLUENZA  VIRUSES  IN  SWINE 
cells, one should not expect an antibody response.  Second, previous 
infection with  swine  virus  might,  in  some  manner,  have  interfered 
with or exhausted  the mechanism responsible for the  elaboration of 
neutralizing antibodies for the  closely related human virus.  In this 
TABLE  IV 
Antibody Response of Swine  Influenza-Convalescent Swine  to  Human  Influenza 
Virus Administered Intramuscularly 
S~um&awn 
Serum tested for  capacity to  neutralize 
Swine influenza  virus  Human  influenza  virus 
Extent of  pulmonary lesions Extent of  pulmonary lesions 
in  mouse No.  in  moase No. 








13 days after  initial  infection 
11 days after  reinoculation 
Normal 
13 days after initial infection 
11 days after reinoculation 
Normal 
13 days after initial infection 
12 days after reinoculation 
Norn'lal 
13 days after initial infection 
12 days after reinoculation 
Normal (not obtained) 
12 days after initial infection 













0  0  0 
0  [0  0 
4+  4+ 
0  0 
0  0 
4+  4+ 
0  0 
0  0 
4+  4+ 
0  0 
0  0 
4+  4+ 
0  0 

















4+  i3+ 




4+  14+ 
4+  4+ 
0  0 
4+  4+ 
4+  4+ 
1+ 
0  4+  O4+  4+ 
0 
* 0  --  mouse  with  no pulmonary lesions  at  autopsy.  1-{- to  4+  =  mice 
with progressive degrees of influenzal pneumonia; 4+ indicates  a complete  and 
fatal pneumonia. 
event,  even though human virus did penetrate  the  respiratory tract 
mucosa, it would be incapable of eliciting a specific antibody response. 
The following experiments were conducted in an attempt to determine 
the applicability of the second hypothesis. glC~A~  E.  SHOPE  165 
Five swine were infected in the usual way with swine influenza.  After re- 
covery they were reinoculated with human influenza virus, but, instead of admin- 
istering the virus intranasally as in the experiments outlined in Table III, it was 
given intramuscularly.  The animals exhibited no  evidence of illness and after 
a period of observation of 11 or 12 days were bled.  Serum obtained at this time, 
together with that secured before and after the swine influenza infections, was 
tested for the presence of neutralizing antibodies for the swine and human influ- 
enza  viruses.  The  results  of  these  neutralization  experiments  are  given  in 
Table IV. 
As shown in Table IV, 3 of the 5  swine influenza-immune swine, 
inoculated intramuscularly with  human influenza  virus,  developed 
antibodies which completely neutralized the human virus; 1 animal, 
swine  1897,  developed antibodies which neutralized partially; while 
the 5th animal, swine 1893, neutralized the human virus partially both 
before and after its intramuscular injection. 
These experiments indicate that  the usual failure of intranasally 
administered human influenza virus to elicit specific neutralizing anti- 
bodies in swine influenza-recovered swine is not due to interference 
with  or  exhaustion  of  the  mechanism  responsible  for  antibody 
elaboration. 
DISCUSSION 
It has been found that swine recovered from infection with swine 
influenza or swine influenza virus alone are usually immune to infec- 
tion with a mixture of human influenza virus and H. influenzae  suis, 
and  that  they rather  promptly render  human virus,  administered 
intranasaily,  non-demonstrable.  This  cross-immunity is  not  asso- 
dated with the presence of demonstrable neutralizing antibodies for 
the human virus in the sera of the immune animals.  Furthermore, 
antibodies for  the  human virus usually  fail  to  develop even  after 
reinoculation intranasally with that agent.  Swine immune to human 
influenza infection, by virtue of a previous attack of swine influenza, 
thus behave towards the human virus much like naturally refractory 
animals in  that  they  are  resistant  to  infection without possessing 
virus-neutralizing antibodies, they do not permit the establishment 
in the respiratory tract of virus given intranasally, and they usually 
fail  to  develop  virus-neutralizing  antibodies  following  intranasal 
inoculation. 
Antibodies against human influenza virus do appear, however, in 166  SWINE  AND  ~  INFLUENZA  VIRUSES  IN SWINE 
the sera of swine influenza-immune  swine to which the human virus is 
given intramuscularly.  This indicates that  their failure to  appear 
after intranasal inoculation is  not due to  interference, by previous 
swine  virus infection, with the mechanism responsible  for antibody 
elaboration.  Rather it suggests that the failure may have resulted 
from inability of the virus to penetrate the respiratory tract mucosa 
deeply enough to produce an antibody response.  It seems likely that, 
in swine, the cross-immunity to human influenza virus established by 
previous infection with swine influenza virus is the result of an acquired 
barrier  to  the  entrance of human virus  into  the  respiratory tract 
mucosa. 
The cross-immunity conferred against swine influenza by the human 
influenza virus differs from that in the reverse direction just discussed, 
and here the association of H. influenzae suis in the initial infection is 
important.  Swine recovered from infection with a mixture of human 
influenza virus and H. influenzae  su,'s are usually immune to  swine 
influenza, while  those  whose initial  infections have  been with  the 
human virus  alone  are  usually still  susceptible  to  swine  influenza, 
although they develop milder attacks than the control animals.  Fur- 
thermore,  while  the  pneumonias  exhibited  by  these  non-immune 
swine  at  autopsy  are  qualitatively  similar  to  those  seen  in  swine 
influenza in fully susceptible animals, swine influenza virus is either 
not demonstrable or is present only in low concentration in the turbi- 
hates and lungs.  This finding is in striking contrast to the uniformity 
with which virus is demonstrable in the lungs and turbinates of the 
control swine. 
Antibodies capable  of neutralizing swine influenza virus  are  not 
present in the sera of animals recovered from human influenza, but 
they do appear in the sera of most such swine following reinoculation 
with swine influenza, and this even in the absence of clinical mani- 
festations of infection.  The finding indicates that the immunity to 
swine virus conferred by previous infection with the human agent is 
not of such a nature as to give rise to a barrier to virus invasion in the 
respiratory tract mucosa of the apparently immune host. 
The fact that the respiratory tract mucosas of swine still let swine 
influenza virus through after recovery from infection with the human 
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bacterium gives a  better immunity to swine influenza than does in- 
fection with human virus alone.  Swine initially infected with a mix- 
ture of human influenza virus and H. influenzae suis develop an immu- 
nity to both agents: immunity to the human virus is evidenced by the 
appearance of specific neutralizing antibodies, while immunity to H. 
influenzae suis is indicated by the failure of this bacterium to become 
established in  the  lower  respiratory  tract  upon reinoculation with 
swine influenza.  Swine initially infected with human influenza virus 
alone, on the other hand, become immune only to this virus.  When 
later inoculated intranasally with a mixture of swine influenza virus 
and H. influemae suis the animals immune to both the human virus 
and H. influenzae suis have only the heterologous virus with which to 
deal.  The swine virus in these cases, to judge by the formation of 
swine virus-neutralizing antibodies, invades the tissues of the respira- 
tory tract and persists for a  short time at least.  That it is rather 
promptly inactivated, however, probably through an immunity  mecha- 
nism established as  a  result of previous infection with  the  closely 
related human virus, is indicated by the fact that, in animals that 
remain free of symptoms, no swine virus can be demonstrated in the 
turbinates or lung even 3 days after inoculation.  The swine show no 
clinical or postmortem evidence of this evanescent virus infection and 
thus, like ferrets and mice, appear to possess a perfect cross-immunity. 
On the other hand, swine immune only to the human virus cannot 
usually  adequately  resist  this  transitory  infection with  the  swine 
influenza virus  when  a  concomitant H. influenzae  suis  infection is 
added.  Even here, however, the virus component  is rapidly destroyed 
in the influenzal, lesions it has initiated, as evidenced by its complete 
absence, or presence only in low concentration, in the turbinates and 
lungs as early as the 3rd day after infection. 
To judge from the two instances in which swine were given 2 intra- 
nasal injections of human influenza virus alone, repeated inoculations 
with the human virus enhance the effectiveness of the cross-immunity 
defense mechanism against swine influenza. 
It  seems likely,  from the experiments discussed,  that  the  cross- 
immunity shown by swine recovered from infection with the viruses 
of human and swine influenza, respectively, may be due to different 
mechanisms.  Animals convalescent from swine influenza are immune 168  SWINE  AND  HUMAN INFLUENZA VIRUSES IN  SWINE 
to human influenza virus apparently by virtue of the failure of the 
human agent to get through the lining of the respiratory tract.  In the 
case of swine  recovered from infection with human influenza virus, 
on the other hand, the respiratory tract mucosa still lets the swine 
influenza virus pass,  but here the invading virus is rather promptly 
inactivated by  some unknown defense mechanism evidently estab- 
lished by the earlier human virus infection. 
The findings recorded were all obtained in "acute" experiments and 
it is possible that other results would be obtained when long periods of 
time intervened between succeeding exposures to infection.  Practical 
considerations, incident to experimental work with swine, have made 
it  impossible  to include such long time experiments in the present 
studies. 
SIYM~R¥ 
Swine recovered from infection with either swine influenza or swine 
influenza virus alone are usually not only immune but refractory to 
human influenza infection.  Swine  recovered from infection with  a 
mixture of human influenza virus and H.  influenzae  suis are usually 
immune to swine influenza while those recovered from infection with 
human influenza virus alone are usually not immune to swine influenza. 
The possible  mechanisms involved in  the  cross-immunity between 
the influenza viruses are discussed. 
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